Page 146 - Clinical Small Animal Internal Medicine
P. 146

114  Section 2  Endocrine Disease

            adrenal insufficiency reported four with concurrent   performed because of continued lethargy despite
  VetBooks.ir  hypothyroidism,  one dog with  concurrent  IDDM  and     adequate mineralocorticoid replacement therapy, persis­
                                                              tent hyponatremia, hypercholesterolemia, dermatologic
            one dog with concurrent primary gonadal hypoplasia.
            A  single case of type 2 APS has been described in a
                                                              In cases of combined DM and hypothyroidism, diabetes
              middle‐aged female dog presenting in a hypothyroid   disease, bradycardia, obesity, and heat‐seeking behavior.
              crisis; treatment of the hypothyroid state resulted in   mellitus insulin resistance is usually the reason for
              precipitation of the hypoadrenocorticism. The presence     thyroid testing.
            of serum autoantibodies to thyroid and adrenal tissue
            was observed in this dog as evidence of APS type 2.
                                                                Diagnosis and Prognosis

              History and Clinical Signs                      In two studies, dogs with concurrent diabetes and hypo­
                                                              thyroidism showed significantly lower serum sodium
            Most of the dogs in reported studies were diagnosed with   concentration and had significantly higher fasting serum
            hypoadrenocorticism initially and the mean age of onset   cholesterol compared with nonhypothyroid diabetic
            of the disease was in young adulthood. Dogs are usually   dogs; similarly, dogs with hypoadrenocorticism com­
            diagnosed with a second endocrinopathy approximately   bined with hypothyroidism exhibited significantly lower
            one year after the first endocrinopathy.          sodium and higher serum cholesterol than dogs with
             A familial tendency was observed in one study where   hypoadrenocorticism alone. These two chemistry abnor­
            two dogs were mother and daughter and one dog had a   malities are highly suggestive of hypothyroidism in a dog
            sibling with hypoadrenocorticism. Hypoadrenocorticism   with otherwise well‐regulated hypoadrenocorticism or
            is inherited in several breeds, including standard  poodles,   in a poorly regulated diabetic dog. Severe hyponatremia
            West Highland white terriers, Nova Scotia duck tolling   (<120 meq/L) is a sign of Schmidt syndrome in humans.
            retrievers, Portuguese water dogs, and Leonbergers; how­  Thyroid testing should be performed in diabetics dogs
            ever, there may be different DLA haplotypes depending   that exhibit poor glucose regulation, persistent hypona­
            on breed. There is a distinct breed predisposition for   tremia and hypercholesterolemia, obesity or weight gain,
              primary hypothyroidism with golden retrievers,   lethargy, dermatologic disease, and regurgitation.
            Doberman pinschers, Irish setters, miniature schnauzers,   Resting serum cortisol concentration is often subnormal
            dachshunds, cocker spaniels, and beagles. Diabetes   (<2 μg/dL) in dogs that suffer from APS 2 that manifests as
              mellitus (type 1a), which has an autoimmune basis, is seen   hypoadrenocorticism and all will show inadequate
            with increased frequency in Samoyeds, Tibetan   terriers,   response to adrenocorticotropic hormone (ACTH) stimu­
            Australian terriers, keeshonds and several other breeds. In   lation. Endogenous ACTH levels should be increased due
            fact, one study showed that the DLA‐DRB1*009/DQA1*/  to primary adrenal insufficiency and loss of negative feed­
            DQB1*008 haplotype was associated with DM in certain   back to the pituitary gland. One reported case of Schmidt
            breeds (Samoyed, Tibetan, and cairn terriers) and that the   syndrome (APS 2) had evidence of lymphocytic adenohy­
            DLA‐DQA1*001 allele is also associated with hypothy­  pophysitis  in  addition  to  adrenalitis and  thyroid  gland
            roidism in dogs, suggesting a common susceptibility allele   atrophy; immune‐mediated pituitary disorders have been
            for canine immune‐mediated endocrinopathies.      reported in humans as well. Mean basal thyroxine (T4)
             A decreasing insulin requirement is often the earliest   and free T4 levels are usually low to low normal and
            sign of adrenal insufficiency in a patient with type 1   endogenous thyroid‐stimulating hormone (TSH) is usu­
              diabetes mellitus secondary to APS in human beings.   ally elevated in dogs with multiple endocrinopathies
            In  contrast, dogs with concurrent hypothyroidism   resulting from APS.
            and IDDM often have increasing insulin requirements;
            hypothyroidism may cause insulin resistance resulting
            from lipid abnormalities or other factors.          Therapy
             The most common presenting complaints for hypoad­
            renocorticism as the initial diagnosis include lethargy,   Treatment of multiple endocrinopathies consists of
            collapse, vomiting, weight loss, weakness, ataxia,  anorexia,     specific  hormone replacement. For dogs with hypoad­
            bradycardia, megaesophagus, and diarrhea. Clinico­  renocorticism, treatment with fludrocortisone (0.018 mg/
            pathologic features include hyponatremia, hypercholes­  kg PO q24h) or deoxycorticosterone pivalate (DOCP)
            terolemia, hyperkalemia, hypochloremia, azotemia,   (1 mg/kg IM monthly) should be initiated first, followed
            hypocalcemia, and hypercalcemia.                  by  levothyroxine  therapy  (22 μg/kg  once  or  twice  daily
             In dogs diagnosed with hypoadrenocorticism as    PO). One should be aware that aggressive levothyroxine
            the  initial endocrinopathy, thyroid evaluation is often   therapy might precipitate a life‐threatening adrenal  crisis
   141   142   143   144   145   146   147   148   149   150   151